These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 25839047)
1. Oncolytic Poxviruses. Chan WM; McFadden G Annu Rev Virol; 2014 Sep; 1(1):119-141. PubMed ID: 25839047 [TBL] [Abstract][Full Text] [Related]
2. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Stanford MM; McFadden G Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330 [TBL] [Abstract][Full Text] [Related]
5. Replicating poxviruses for human cancer therapy. Kim M J Microbiol; 2015 Apr; 53(4):209-18. PubMed ID: 25845536 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic myxoma virus: the path to clinic. Chan WM; Rahman MM; McFadden G Vaccine; 2013 Sep; 31(39):4252-8. PubMed ID: 23726825 [TBL] [Abstract][Full Text] [Related]
7. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594. Breitbach CJ; Thorne SH; Bell JC; Kirn DH Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365 [TBL] [Abstract][Full Text] [Related]
8. The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses. Mundi N; Um S; Yoo J; Rizzo G; Black M; Pinto N; Palma DA; Fung K; MacNeil D; Mymryk JS; Barrett JW; Nichols AC Virus Res; 2014 Sep; 190():53-9. PubMed ID: 25038405 [TBL] [Abstract][Full Text] [Related]
9. Application of Oncolytic Poxviruses: An Emerging Paradigm in Cancer Therapy. Chakraborty P; Kumar R; Karn S; Raviya DD; Mondal P Adv Exp Med Biol; 2024; 1451():369-381. PubMed ID: 38801591 [TBL] [Abstract][Full Text] [Related]
11. Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. Enow JA; Sheikh HI; Rahman MM Viruses; 2023 Nov; 15(11):. PubMed ID: 38005938 [TBL] [Abstract][Full Text] [Related]
12. Recent progress in combination therapy of oncolytic vaccinia virus. Mirbahari SN; Da Silva M; Zúñiga AIM; Kooshki Zamani N; St-Laurent G; Totonchi M; Azad T Front Immunol; 2024; 15():1272351. PubMed ID: 38558795 [TBL] [Abstract][Full Text] [Related]
13. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses. Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547 [TBL] [Abstract][Full Text] [Related]
14. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells. Stanford MM; Barrett JW; Nazarian SH; Werden S; McFadden G J Virol; 2007 Feb; 81(3):1251-60. PubMed ID: 17108021 [TBL] [Abstract][Full Text] [Related]
15. Virus combinations and chemotherapy for the treatment of human cancers. Kumar S; Gao L; Yeagy B; Reid T Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102 [TBL] [Abstract][Full Text] [Related]
17. [Current state of oncolytic virotherapy in Japan]. Nakamori M; Yamaue H Gan To Kagaku Ryoho; 2013 May; 40(5):553-8. PubMed ID: 23863576 [TBL] [Abstract][Full Text] [Related]
18. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells. McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818 [TBL] [Abstract][Full Text] [Related]
19. Virus, Oncolytic Virus and Human Prostate Cancer. Liu GB; Zhao L; Zhang L; Zhao KN Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115 [TBL] [Abstract][Full Text] [Related]